Breaking News

MilliporeSigma Opens €290M CDMO Facility in Rockville, MD

Facility consolidates biosafety testing, analytical development, and cell bank manufacturing services into single building.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has opened its new €290 million biosafety testing facility in Rockville, MD, to meet growing demand for biosafety testing and analytical development.     The 23,000-square-meter facility will house biosafety testing, analytical development, and cell banking manufacturing services. It consolidates labs currently spread across four buildings into a single facility. This aims to increase collaboration bet...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters